Assessment of Procalcitonin to Predict Outcome in Hypothermia-Treated Patients after Cardiac Arrest

Table 1

Main demographic and Utstein data.

	Good outcome (𝑛=27)	Bad outcome (𝑛=26)	P
Age (years)	61 (49–68)	67 (59–72)	0.06
SAPS II	59 (52–66)	72 (66–77)	<0.0001
Male (𝑛)	23 (85%)	19 (73%)	0.23
OHCA (𝑛)	20 (74%)	20 (80%)	0.53
Time to ROSC (min)	20 (10–30)	30 (23–36)	0.005
Time CA to TT (min)	280 (215–340)	285 (176–335)	0.73
Initial rhythm			0.20
VF/VT	23 (85%)	12 (46%)
Asystole	2 (7.5%)	8 (31%)
PEA	2 (7.5%)	6 (23%)
Cardiogenic shock (𝑛)	7 (26%)	14 (54%)	0.04
Coronary intervention (𝑛)	24 (89%)	21 (81%)	0.41
Pneumonia (𝑛)	12 (44%)	8 (31%)	0.30
Sepsis (𝑛)	3 (11%)	2 (7.7%)	0.68
Antibiotics treatment (𝑛)	25 (93%)	14 (54%)	0.001

SAPS simplified acute physiology score; OHCA out of hospital cardiac arrest; ROSC return of spontaneous circulation; CA cardiac arrest; TT target temperature; VF/VT ventricular fibrillation/ventricular tachycardia; PEA pulseless electric activity.